Compare Novavax Inc (NVAX) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Energy Select Sector SPDR Fund — how do they compare? Novavax Inc trades at $9.85 (market cap $1.62B), while Energy Select Sector SPDR Fund trades at $65.7. The key difference: Energy Select Sector SPDR Fund is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | XLE | |
|---|---|---|
Market Cap | $1.62B | — |
Sector | Health | — |
52-Week High | $11.19 | $65.31 |
52-Week Low | $6.22 | $42.61 |
Enterprise Value | $1.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $10.19, down 0.29% today, with a bullish technical signal from moving averages but overbought RSI levels. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 revenue outlook. Key developments include regulatory approvals for its updated COVID-19 vaccine in the U.S., EU, and Japan for the 2026-2027 season, alongside ongoing partnerships with Sanofi and Pfizer.
The outlook is mixed: strong analyst buy ratings (73.9%) and partnership milestones offer upside, but negative net income margins and cash flow challenges pose risks. Investors should weigh the potential from vaccine demand and adjuvant platform royalties against financial sustainability concerns and competitive pressures in the biotech sector.
XLE, the Energy Select Sector SPDR ETF, trades at $64.78, up 1.12% amid bullish technical signals and strong sector momentum. The ETF benefits from rising oil prices, with Brent crude exceeding $100 per barrel due to Middle East tensions, as reported by Reuters on September 9, 2026. Technical indicators show a bullish moving average consensus, though the 6-day RSI at 78.15 suggests potential overbought conditions. Recent performance includes a 7.4% gain in August, leading sector ETFs, per ETF Trends on September 2, 2026.
Outlook remains positive driven by geopolitical supply risks and institutional optimism, with Goldman Sachs forecasting oil could reach $120 (Zacks, September 8, 2026). Key risks include oil price volatility and refining capacity constraints. The ETF's concentration in large caps like Exxon and Chevron offers stability, but investors face exposure to energy market cyclicality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
